Bespoke Extracts (BSPK) Assets Growth (5y) (2016 - 2021)
Bespoke Extracts (BSPK) Assets Growth (5y) (2016 - 2021) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2021 | 33.60% |
| Aug 31, 2021 | 134.79% |
| May 31, 2021 | 120.24% |
| Feb 28, 2021 | 78.78% |
| Nov 30, 2020 | 8.96% |
| Aug 31, 2020 | -10.07% |
| May 31, 2020 | -38.50% |
| Feb 29, 2020 | -30.40% |
| Nov 30, 2019 | -28.11% |
| Aug 31, 2019 | -36.64% |
| May 31, 2019 | -23.27% |
| Feb 28, 2019 | -22.98% |
| Nov 30, 2018 | -25.31% |
| Aug 31, 2018 | -20.41% |
| May 31, 2018 | -10.23% |
| Feb 28, 2018 | -17.60% |
| Nov 30, 2017 | -15.48% |
| Aug 31, 2017 | -27.08% |
| May 31, 2017 | -25.37% |
| Feb 28, 2017 | -43.19% |